Next Generation Sequencing (NGS) Market - By Product Type: Instruments, Reagents and Consumables, Services; By Technology: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing; By Application: Clinical Diagnostics, Drug Discovery, Research; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.6 Global Next Generation Sequencing (NGS) Market - Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Region, 2024 - 2031
9. North America Global Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Instruments
9.1.2 Reagents and Consumables
9.1.3 Services
9.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Whole Genome Sequencing
9.2.2 Whole Exome Sequencing
9.2.3 Targeted Sequencing
9.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Clinical Diagnostics
9.3.2 Drug Discovery
9.3.3 Research
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 United States
9.4.2 Canada
9.5 North America
Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America Global Next Generation Sequencing (NGS) Market Research Report - Company Profiles
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
10. Europe Global Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.1.1 Instruments
10.1.2 Reagents and Consumables
10.1.3 Services
10.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.2.1 Whole Genome Sequencing
10.2.2 Whole Exome Sequencing
10.2.3 Targeted Sequencing
10.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.3.1 Clinical Diagnostics
10.3.2 Drug Discovery
10.3.3 Research
10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.4.1 Germany
10.4.2 United Kingdom
10.4.3 France
10.4.4 Spain
10.4.5 Italy
10.4.6 Russia
10.4.7 Netherlands
10.4.8 Poland
10.4.9 Rest of Europe
10.5 Europe
Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Country, 2024 - 2031
10.6 Regional Trends Analysis
10.7 Europe Global Next Generation Sequencing (NGS) Market Research Report - Company Profiles
10.7.1 Company 1 (Germany)
10.7.2 Company 2 (United Kingdom)
10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.1.1 Instruments
11.1.2 Reagents and Consumables
11.1.3 Services
11.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.2.1 Whole Genome Sequencing
11.2.2 Whole Exome Sequencing
11.2.3 Targeted Sequencing
11.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.3.1 Clinical Diagnostics
11.3.2 Drug Discovery
11.3.3 Research
11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia & NZ
11.4.6 ASEAN
11.4.7 Rest of Asia-Pacific
11.5 Asia-Pacific
Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Country, 2024 - 2031
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Next Generation Sequencing (NGS) Market Research Report - Company Profiles
11.7.1 Company 1 (China)
11.7.2 Company 2 (Japan)
11.7.3 Company 3 (Japan)
12. Latin America Global Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.1.1 Instruments
12.1.2 Reagents and Consumables
12.1.3 Services
12.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.2.1 Whole Genome Sequencing
12.2.2 Whole Exome Sequencing
12.2.3 Targeted Sequencing
12.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.3.1 Clinical Diagnostics
12.3.2 Drug Discovery
12.3.3 Research
12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Peru
12.4.5 Colombia
12.4.6 Rest of Latin America
12.5 Latin America
Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Country, 2024 - 2031
12.6 Regional Trends Analysis
12.7 Latin America Global Next Generation Sequencing (NGS) Market Research Report - Company Profiles
12.7.1 Company 1 (Brazil)
12.7.2 Company 2 (Mexico)
12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.1.1 Instruments
13.1.2 Reagents and Consumables
13.1.3 Services
13.2 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.2.1 Whole Genome Sequencing
13.2.2 Whole Exome Sequencing
13.2.3 Targeted Sequencing
13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.3.1 Clinical Diagnostics
13.3.2 Drug Discovery
13.3.3 Research
13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.4.1 Saudi Arabia
13.4.2 UAE
13.4.3 South Africa
13.4.4 Egypt
13.4.5 Israel
13.4.6 Rest of Middle East and Africa
13.5 Middle East & Africa
Global Next Generation Sequencing (NGS) Market – Opportunity Analysis Index,
By Product Type,
By Technology,
By Application,
and Country, 2024 - 2031
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Next Generation Sequencing (NGS) Market Research Report - Company Profiles
13.7.1 Company 1 (Saudi Arabia)
13.7.2 Company 2 (UAE)
13.7.3 Company 3 (UAE)
14. Competition Landscape
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
14.2.1 Illumina Inc.
14.2.2 Thermo Fisher Scientific
14.2.3 BGI Genomics
14.2.4 Oxford Nanopore Technologies
14.2.5 Pacific Biosciences
15. Data Collection Method and Research Approach 16. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.